skip to main content
10.1145/3448748.3448753acmotherconferencesArticle/Chapter ViewAbstractPublication PagesbicConference Proceedingsconference-collections
research-article

RNA-seq Reveals the Increased Risk of Heart and Cardiovascular Disease by SARS-CoV-2 Infection

Published: 21 March 2021 Publication History

Abstract

As of late 2020, much is still unknown about the novel SARS-CoV-2 virus, including what health risks could be present for current patients. We know that while being infected with the disease, patients are struck with many respiratory issues. However, little is known about the long-term effects COVID-19 survivors could be affected by. Using differential expression analysis, we identified several differentially expressed genes in COVID-19 positive patients that indicate an increase in the risk for heart disease in these patients - APOL3, KLF15, and CD163. These genes indicate an increase of risk for cardiovascular disease through increased apolipoprotein levels, decreased negative regulators for risk factors, and increased inflammation and infection.

References

[1]
Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395: 507--513.
[2]
Wolfel R., Corman V.M., Guggemos W., Seilmaier M., Zange S., Muller M.A., Niemeyer D., Jones T.C., Vollmar P., Rothe C. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020
[3]
Xu Z., Shi L., Wang Y., Zhang J., Huang L., Zhang C., Liu S., Zhao P., Liu H., Zhu L. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 2020; 8: 420--422.
[4]
Lippi G, Plebani M. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. Clin Chim Acta. 2020; 505: 190--191.
[5]
Forster P, Forster L, Renfrew C, Forster M. Phylogenetic network analysis of SARS-CoV-2 genomes. Proc Natl Acad Sci USA2020;117(17): 9241--9243.
[6]
Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany NY). 2020;12(7): 6049--6057.
[7]
Costa-Silva J, Domingues D, Lopes FM (2017) RNA-Seq differential expression analysis: An extended review and a software tool. PLoS ONE 12(12): e0190152. https://doi.org/10.1371/journal.pone.0190152
[8]
Nicole A. P. Lieberman, et al. "In vivo antiviral host response to SARS-CoV-2 by viral load, sex, and age." bioRxiv 2020.06.22.165225;
[9]
Love, M.I. et al. (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biology, 15.
[10]
Robinson M.D. et al. (2009) edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics, 26, 139--140.
[11]
Benjamini Y. and Hochberg Y. (1995) Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society: Series B (Methodological), 57, 289--300.
[12]
Khalil, Alia, et al. "Apolipoprotein L3 Interferes with Endothelial Tube Formation via Regulation of ERK1/2, FAK and Akt Signaling Pathway." Atherosclerosis, vol. 279, 2018, pp. 73--87.
[13]
Patel, Sheila K., et al. "Kruppel-Like Factor 15 Is Critical for the Development of Left Ventricular Hypertrophy." International Journal of Molecular Sciences, vol. 19, no. 5, Apr. 2018. Central.
[14]
Wang, Junning, et al. "Elevated Soluble CD163 Plasma Levels Are Associated with Disease Severity in Patients with Hemorrhagic Fever with Renal Syndrome." PLOS ONE, vol. 9, no. 11, Nov. 2014, p. e112127. PLoS Journals.

Index Terms

  1. RNA-seq Reveals the Increased Risk of Heart and Cardiovascular Disease by SARS-CoV-2 Infection

        Recommendations

        Comments

        Information & Contributors

        Information

        Published In

        cover image ACM Other conferences
        BIC '21: Proceedings of the 2021 International Conference on Bioinformatics and Intelligent Computing
        January 2021
        445 pages
        ISBN:9781450390002
        DOI:10.1145/3448748
        Permission to make digital or hard copies of all or part of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for profit or commercial advantage and that copies bear this notice and the full citation on the first page. Copyrights for components of this work owned by others than ACM must be honored. Abstracting with credit is permitted. To copy otherwise, or republish, to post on servers or to redistribute to lists, requires prior specific permission and/or a fee. Request permissions from [email protected]

        In-Cooperation

        • University of Arizona: University of Arizona

        Publisher

        Association for Computing Machinery

        New York, NY, United States

        Publication History

        Published: 21 March 2021

        Permissions

        Request permissions for this article.

        Check for updates

        Author Tags

        1. COVID-19
        2. RNA-seq
        3. SARS-CoV-2 infection

        Qualifiers

        • Research-article
        • Research
        • Refereed limited

        Conference

        BIC 2021

        Contributors

        Other Metrics

        Bibliometrics & Citations

        Bibliometrics

        Article Metrics

        • 0
          Total Citations
        • 60
          Total Downloads
        • Downloads (Last 12 months)5
        • Downloads (Last 6 weeks)1
        Reflects downloads up to 08 Mar 2025

        Other Metrics

        Citations

        View Options

        Login options

        View options

        PDF

        View or Download as a PDF file.

        PDF

        eReader

        View online with eReader.

        eReader

        Figures

        Tables

        Media

        Share

        Share

        Share this Publication link

        Share on social media